Ebola Vaccines: Biomedical Advances, Human Rights Challenges: Commentary on: A Randomized, Blinded, Dose-Ranging Trial of an Ebola Virus Glycoprotein (EBOVGP) Nanoparticle Vaccine With Matrix-M Adjuvant in Healthy Adults